Avidity Biosciences
RNA
#1891
Rank
NZ$18.75 B
Marketcap
NZ$121.43
Share price
-0.23%
Change (1 day)
127.78%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: NZ$18.75 Billion

As of February 2026 Avidity Biosciences has a market cap of NZ$18.75 Billion. This makes Avidity Biosciences the world's 1891th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$18.75 B-0.04%
2025NZ$18.76 B194.61%
2024NZ$6.36 B462.18%
2023NZ$1.13 B-51.22%
2022NZ$2.32 B42.33%
2021NZ$1.63 B22.96%
2020NZ$1.32 B

End of Day market cap according to different sources

On Feb 24th, 2026 the market cap of Avidity Biosciences was reported to be:

NZ$18.29 Billion
by Nasdaq info icon info icon
NZ$18.75 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$257.57 B 1,273.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$198.02 B 955.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$3.29 B-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
NZ$9.24 B-50.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.31 B-98.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.37 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.24 B-2.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$4.96 B-73.54%๐Ÿ‡บ๐Ÿ‡ธ USA